Onesource Specialty Pharma Limited (ONESOURCE) — Board Meeting | 24 July 2026(2 announcements)

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Approved allotment of 2,900 ESOP shares
🔄 What Changed
Paid-up capital rose from INR 11,46,69,991 to INR 11,46,72,891
💡 Investor Takeaway
The ESOP issuance expands share count but does not alter capital structure meaningfully.

On July 24, 2026, OneSource Specialty Pharma approved the allotment of 2,900 equity shares of INR 1 each under its Employee Stock Option Plan 2021, increasing paid-up capital from INR 11,46,69,991 to INR 11,46,72,891. The shares rank pari passu with existing shares and were issued at an exercise price of INR 278 per share.

2 Board Meeting 🟡 Notable Neutral 📄 PDF
📢 Key Event
Board approved unaudited Q1 FY26 consolidated financial results
💡 Investor Takeaway
The company reported a small quarterly loss with no material issues flagged, indicating stable but loss-making operations.

Onesource Specialty Pharma Limited disclosed unaudited consolidated financial results for Q1 FY2026 ending June 30, 2026, showing a net loss of ₹12.14 million and total comprehensive income of ₹12.44 million. The board-approved results were reviewed by Deloitte Haskins & Sells, which confirmed no material misstatements or omitted disclosures under SEBI LODR Regulation 33. The review covered seven subsidiaries, excluding two entities with immaterial financials and four subsidiaries with zero revenue and minor losses, deemed non-material per management explanation.

About Onesource Specialty Pharma Limited (ONESOURCE)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹17,366.55 Cr ROE: -0.8% ROCE: 0.9%

View full ONESOURCE stock details →

📡 Get AI alerts when ONESOURCE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ONESOURCE — Free

📊 More ONESOURCE filings

See all ONESOURCE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ONESOURCE files new disclosures

Track ONESOURCE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ONESOURCE — Free

Free account · 2 AI queries/day